Proof-of-concept trial of Goal Management Training plus to improve executive functions and treatment outcomes in methamphetamine use disorder

被引:5
作者
Anderson, Alexandra C. [1 ,2 ,6 ]
Robinson, Alex H. [1 ,2 ,6 ]
Giddens, Emily [1 ,2 ]
Hartshorn, Breanna [1 ,2 ]
Allan, Eric [3 ]
Rowe, Carol [3 ]
Lawrence, Toby [4 ]
Chong, Trevor T. -J. [1 ,2 ]
Lubman, Dan I. [5 ,6 ]
Verdejo-Garcia, Antonio [1 ,2 ,6 ]
机构
[1] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia
[2] Monash Univ, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia
[3] Odyssey House Victoria, Melbourne, Vic, Australia
[4] Arrow Hlth, Armadale, Vic, Australia
[5] Eastern Hlth, Turning Point, Clayton, Vic, Australia
[6] Monash Univ, Monash Addict Res Ctr, Clayton, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会;
关键词
Methamphetamine; Addiction; Executive function; Impulsivity; Cognitive remediation; Goal management training; ADDICTION TREATMENT OUTCOMES; SUBSTANCE USE DISORDER; PSYCHOMETRIC PROPERTIES; POLYSUBSTANCE USERS; FRONTAL-LOBE; DEFICITS; IMPULSIVITY; LIFE; REHABILITATION; INDIVIDUALS;
D O I
10.1016/j.drugalcdep.2023.109846
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Deficits in executive function are common in methamphetamine use disorder (MUD), likely contributing to difficulties in sustained treatment success. Cognitive remediation interventions are designed to treat such deficits but have not been adapted to the needs of people with MUD. This study presents a proof-of -concept trial to evaluate a new cognitive remediation program for MUD, Goal Management Training+ (GMT+).Methods: This was a cluster-randomised crossover trial comparing GMT+ with a psychoeducation-based control (Brain Health Workshop; BHW). GMT+ is a therapist-administered group-based cognitive remediation for ex-ecutive dysfunction comprising four 90-minute weekly sessions and daily journal activities. BHW is a lifestyle psychoeducation program matched to GMT+ for therapist involvement, format, and duration. Participants (n = 36; GMT n = 17; BHW n = 19) were recruited from therapeutic communities in Victoria, Australia. Primary outcomes included intervention acceptability, feasibility, and improvements in self-reported executive function. Secondary outcomes included cognitive tests of executive function, severity of methamphetamine dependence, craving, and quality of life. We performed mixed linear modelling and calculated Hedges' g effect sizes.Results: GMT+ participant ratings and program retention indicated high acceptability. There was no difference between GMT+ and BHW on self-reported executive function (g = 0.06). Cognitive tasks suggested benefits of GMT+ on information gathering (g = 0.88) and delay-discounting (g = 0.80). Severity of methamphetamine dependence decreased more in GMT+ (g = 1.47).Conclusions: GMT+ was well-accepted but did not improve self-reported executive functioning. Secondary out-comes suggested GMT+ was beneficial for objective cognitive performance and severity of dependence.
引用
收藏
页数:12
相关论文
共 78 条
  • [41] Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)
    McKetin, Rebecca
    Najman, Jake M.
    Baker, Amanda L.
    Lubman, Dan I.
    Dawe, Sharon
    Ali, Robert
    Lee, Nicole K.
    Mattick, Richard P.
    Mamun, Abdullah
    [J]. ADDICTION, 2012, 107 (11) : 1998 - 2008
  • [42] Neuropsychological changes in patients with substance use disorder after completion of a one month intensive outpatient treatment program
    McKowen, James W.
    Isenberg, Benjamin M.
    Carrellas, Nicholas W.
    Zulauf, Courtney A.
    Ward, Nalan E.
    Fried, Ronna S.
    Wilens, Timothy E.
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (08) : 632 - 638
  • [43] The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: A latent variable analysis
    Miyake, A
    Friedman, NP
    Emerson, MJ
    Witzki, AH
    Howerter, A
    Wager, TD
    [J]. COGNITIVE PSYCHOLOGY, 2000, 41 (01) : 49 - 100
  • [44] Murphy B., 2000, AUSTR WHOQOL INSTRUM
  • [45] Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review
    Nardo, Talia
    Batchelor, Jennifer
    Berry, Jamie
    Francis, Heather
    Jafar, Deyyan
    Borchard, Thomas
    [J]. NEUROPSYCHOLOGY REVIEW, 2022, 32 (01) : 161 - 191
  • [46] The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
    Nasreddine, ZS
    Phillips, NA
    Bédirian, V
    Charbonneau, S
    Whitehead, V
    Collin, I
    Cummings, JL
    Chertkow, H
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : 695 - 699
  • [47] Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health
    Onken, Lisa S.
    Carroll, Kathleen M.
    Shoham, Varda
    Cuthbert, Bruce N.
    Riddle, Melissa
    [J]. CLINICAL PSYCHOLOGICAL SCIENCE, 2014, 2 (01) : 22 - 34
  • [48] Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder A Review
    Paulus, Martin P.
    Stewart, Jennifer L.
    [J]. JAMA PSYCHIATRY, 2020, 77 (09) : 959 - 966
  • [49] Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis
    Potvin, Stephane
    Pelletier, Julie
    Grot, Stephanie
    Hebert, Catherine
    Barr, Alasdair M.
    Lecomte, Tania
    [J]. ADDICTIVE BEHAVIORS, 2018, 80 : 154 - 160
  • [50] A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence
    Quinn, Brendan
    Ward, Bernadette
    Agius, Paul A.
    Jenkinson, Rebecca
    Hickman, Matthew
    Sutton, Keith
    Hall, Cristal
    McKetin, Rebecca
    Farrell, Michael
    Cossar, Reece
    Dietze, Paul M.
    [J]. DRUG AND ALCOHOL REVIEW, 2021, 40 (07) : 1239 - 1248